Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
NCT07264933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750
Last updated 2026-02-27
Summary
The purpose of the study is to determine whether immediate postplacental copper T380A intrauterine device insertion increases uterine-niche incidence compared with postpartum progestin-only pills after primary cesarean section .
Conditions
- Scar Niche
- Myometrial Remodeling
- Contraceptive Device; Complications
- Cesarean Section Complications
Interventions
- PROCEDURE
-
Primary Cesarean Section
All lower-segment cesarean sections were performed by qualified obstetricians at Benha University Hospitals who were trained on the study protocol. The standard Kerr technique was used for the uterine incision, followed by double-layer continuous myometrial closure with braided polyglycolic acid 0-1 sutures, with decidual sparing and visceral peritoneal closure.
- DEVICE
-
immediate postplacental insertion of a copper T380A intrauterine device
immediate postplacental insertion of a copper T380A intrauterine device was performed intraoperatively using the standardized intracesarean introducer-withdrawal technique. The intrauterine device introducer with the intrauterine device threads inside is trimmed to 12 cm. The uterus is held and stabilized with the non-dominant hand, and the introducer is inserted first downwards through the cervical canal before pushing it up to put it firmly against the endometrium of the uterine fundus. Then, it is pulled gently down through the cervical canal to the vagina while pressing on the fundus with the non-dominant hand, thus ensuring that the intrauterine device is kept at the fundus and that the intrauterine device threads are in the cervical canal. the introducer is removed gently manually from the vagina at the end of the cesarean section after closure of the skin and ceiling of the wound .
- DRUG
-
progesterone-only pills
Participants were instructed to initiate daily oral intake of progesterone-only pills containing 0.03 mg levonorgestrel per pill (Microlut®; Bayer) at 4 weeks postpartum and at least 5 days before resuming sexual activity. The participants were asked to use it continuously at least till the end of the 6th month postpartum. This product is commercially available in Egypt and contains 35 active tablets per pack.
- DIAGNOSTIC_TEST
-
Transvaginal ultrasound
Two independent, trained sonographers-blinded to each other's findings- will perform transvaginal ultrasound examinations in both sagittal and coronal planes. At 3 and 6 months postpartum,intrauterine device displacement is considered if the distance between the dome of the uterine cavity to the upper part of the intrauterine device is \> 3 mm and these participants will be excluded from the final analysis . At 3 and 6 months postpartum, a niche is defined as an indentation ≥2 mm in the myometrium at the previous cesarean scar site. At 6 months postpartum uterine niche depth, length, width and residual myometrial thickness are to be recorded .
Sponsors & Collaborators
-
Benha University
lead OTHER
Principal Investigators
-
AHMED ALNEZAMY, MD · Lecturer of Obstetrics and Gynecology, Faculty of Medicine, Benha University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-12
- Primary Completion
- 2025-08-05
- Completion
- 2026-02-05
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of a Novel and Simplified Technique for Intrauterine Contraceptive Devices Insertion: a Prospective Cohort Study
NCT02841826 ·Status: COMPLETED ·Phase: PHASE2
-
Saline Sonohystrography and Office Hysteroscopy in Evaluation of Cases of Abnormal Uterine Bleeding
NCT03135353 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Uterine Size and Posture on Intrauterine Contraception in Nulliparous Women
NCT01685164 ·Status: COMPLETED
-
A Novel IUD Insertion Technique
NCT02582268 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Guided Intra-uterine Device Insertion
NCT02393495 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy of Saline Sonohystrography vs. 3D Transvaginal Ultrasound for Cesarean Scar Defect Assessment
NCT05996926 ·Status: UNKNOWN ·Phase: NA
-
The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta
NCT02590484 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Evaluation Versus Direct Measurement of Uterine Cavity Length
NCT04425577 ·Status: COMPLETED ·Phase: NA
-
Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques
NCT03724708 ·Status: UNKNOWN ·Phase: NA
-
Real-time Ultrasound Guided Labor Epidural Placement
NCT00811304 ·Status: WITHDRAWN
-
Endometrial Injury for Unexplained Infertility
NCT02863198 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Uterine Cavity in Perimenopausal Women.
NCT06888414 ·Status: ACTIVE_NOT_RECRUITING
-
Intraoperative Ureteric Dissection vs Preoperative Ureteric Stenting in Women With Abnormally Invasive Placenta
NCT03763916 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between the Role of Transabdominal Ultrasound Versus Transvaginal Ultrasound in Evaluation of Placental Invasion in Cases of Placenta Previa Anterior Wall With Previous Uterine Scar
NCT03437291 ·Status: UNKNOWN
-
Hysteroscopic Guided Versus Ultrasound Guided Extraction of Retained IUD
NCT06550544 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta
NCT02878187 ·Status: COMPLETED
-
Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET
NCT02008240 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998 ·Status: UNKNOWN
-
Preoperative and Intraoperative Sonographic Assessment of Lower Uterine Segment Thickness at Term in Women With Previous Cesarean Delivery - a Ultrasound Method Comparison Study
NCT02827604 ·Status: COMPLETED
-
Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy
NCT04996498 ·Status: COMPLETED ·Phase: NA
-
Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa
NCT02002026 ·Status: COMPLETED ·Phase: NA
-
Study About Patients Using Copper Intrauterine Device
NCT01541241 ·Status: COMPLETED
-
Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI
NCT02660294 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin
NCT05152667 ·Status: UNKNOWN
-
Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar
NCT03859258 ·Status: COMPLETED